{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:25:53Z","timestamp":1790814353373,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12185-014-1626-7","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T05:47:42Z","timestamp":1406008062000},"page":"266-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hepcidin and GDF15 in anemia of multiple myeloma"],"prefix":"10.1007","volume":"100","author":[{"given":"Shuchong","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erbao","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"A Robert","year":"2008","unstructured":"Robert A, Kyleand S, Rajkumar V, et al. Multiple myeloma. Blood. 2008;111:2962\u201372.","journal-title":"Blood"},{"key":"1626_CR2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12185-009-0378-2","volume":"90","author":"T Caravita","year":"2009","unstructured":"Caravita T, Siniscalchi A, Montanaro M, et al. High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients. Int J Hematol. 2009;90:270\u20132.","journal-title":"Int J Hematol"},{"key":"1626_CR3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mehy.2005.08.041","volume":"66","author":"A Cucuianu","year":"2006","unstructured":"Cucuianu A, Patiu M, Rusu A. Hepcidin and multiple myeloma related anemia. Med Hypotheses. 2006;66:352\u20134.","journal-title":"Med Hypotheses"},{"issue":"Suppl 1","key":"1626_CR4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3816\/CLM.2003.s.005","volume":"4","author":"M Mittelman","year":"2003","unstructured":"Mittelman M. The implications of anemia in multiple myeloma. Clin Lymphoma. 2003;4(Suppl 1):S23\u20139.","journal-title":"Clin Lymphoma"},{"key":"1626_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02983379","volume":"78","author":"F Silvestris","year":"2003","unstructured":"Silvestris F, Tucci M, Quatraro C, et al. Recent advances in understanding the pathogenesis of anemia in multiple myeloma. Int J Hematol. 2003;78:121\u20135.","journal-title":"Int J Hematol"},{"key":"1626_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.exphem.2007.01.026","volume":"35","author":"LT Goodnough","year":"2007","unstructured":"Goodnough LT. Erythropoietin and iron-restricted erythropoiesis. Exp Hematol. 2007;35:167\u201372.","journal-title":"Exp Hematol"},{"key":"1626_CR7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","volume":"13","author":"T Tanno","year":"2007","unstructured":"Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13:1096\u2013101.","journal-title":"Nat Med"},{"key":"1626_CR8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.lfs.2005.09.053","volume":"78","author":"X Liu","year":"2006","unstructured":"Liu X, Xie W, Liu P, et al. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia\u2013reperfusion. Life Sci. 2006;78:2255\u201364.","journal-title":"Life Sci"},{"key":"1626_CR9","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2005-06-2259","volume":"107","author":"C Peyssonnaux","year":"2006","unstructured":"Peyssonnaux C, Zinkernagel AS, Datta V, et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107:3727\u201332.","journal-title":"Blood"},{"key":"1626_CR10","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","volume":"111","author":"I Theurl","year":"2008","unstructured":"Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111:2392\u20139.","journal-title":"Blood"},{"key":"1626_CR11","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","volume":"112","author":"T Ganz","year":"2008","unstructured":"Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood. 2008;112:4292\u20137.","journal-title":"Blood"},{"key":"1626_CR12","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/1078-0432.CCR-07-4153","volume":"14","author":"S Sharma","year":"2008","unstructured":"Sharma S, Nemeth E, Chen YH, et al. Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res. 2008;14:3262\u20137.","journal-title":"Clin Cancer Res"},{"key":"1626_CR13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-0609.2006.00739.x","volume":"77","author":"G Birgeg\u00e5rd","year":"2006","unstructured":"Birgeg\u00e5rd G, Gascon P, Ludwig H. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY. Eur J Haematol. 2006;77:378\u201386.","journal-title":"Eur J Haematol"},{"key":"1626_CR14","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","volume":"101","author":"E Nemeth","year":"2003","unstructured":"Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood. 2003;101:2461\u20133.","journal-title":"Blood"},{"key":"1626_CR15","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig. 2004;113:1271\u20136.","journal-title":"J Clin Investig"},{"key":"1626_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2007.06728.x","volume":"139","author":"J Truksa","year":"2007","unstructured":"Truksa J, Peng H, Lee P, Beutler E. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9. Br J Haematol. 2007;139:138\u201347.","journal-title":"Br J Haematol"},{"key":"1626_CR17","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2010-03-274571","volume":"116","author":"K Maes","year":"2010","unstructured":"Maes K, Nemeth E, Roodman GD, et al. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood. 2010;116:3635\u201344.","journal-title":"Blood"},{"key":"1626_CR18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2008-03-143354","volume":"112","author":"L Kautz","year":"2008","unstructured":"Kautz L, Meynard D, Monnier A, et al. Iron regulates phosphorylation of Smad1\/5\/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008;112:1503\u20139.","journal-title":"Blood"},{"key":"1626_CR19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","volume":"41","author":"D Meynard","year":"2009","unstructured":"Meynard D, Kautz L, Darnaud V, et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009;41:478\u201381.","journal-title":"Nat Genet"},{"key":"1626_CR20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","volume":"41","author":"B Andriopoulos","year":"2009","unstructured":"Andriopoulos B, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41:482\u20137.","journal-title":"Nat Genet"},{"key":"1626_CR21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ajh.21448","volume":"84","author":"E Katodritou","year":"2009","unstructured":"Katodritou E, Ganz T, Terpos E, et al. Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response. Am J Hematol. 2009;84:524\u20136.","journal-title":"Am J Hematol"},{"key":"1626_CR22","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","volume":"108","author":"DM Wrighting","year":"2006","unstructured":"Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204\u20139.","journal-title":"Blood"},{"key":"1626_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000354835","volume":"131","author":"P Tarkun","year":"2013","unstructured":"Tarkun P, Birtas Atesoglu E, Mehtap O, et al. Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients. Acta Haematol. 2013;131:173\u20138.","journal-title":"Acta Haematol"},{"key":"1626_CR24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1158\/0008-5472.CAN-11-0188","volume":"72","author":"J Corre","year":"2012","unstructured":"Corre J, Labat E, Espagnolle N, et al. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Res. 2012;72:1395\u2013406.","journal-title":"Cancer Res"},{"key":"1626_CR25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood-2013-08-524025","volume":"123","author":"T Tanno","year":"2014","unstructured":"Tanno T, Lim Y, Wang Q, et al. Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. Blood. 2014;123:725\u201333.","journal-title":"Blood"},{"key":"1626_CR26","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2008-06-165738","volume":"112","author":"H Tamary","year":"2008","unstructured":"Tamary H, Shalev H, Perez-Avraham G. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood. 2008;112:5241\u20134.","journal-title":"Blood"},{"key":"1626_CR27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.exphem.2005.07.008","volume":"33","author":"S Aizawa","year":"2005","unstructured":"Aizawa S, Harada T, Kanbe E, et al. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity. Exp Hematol. 2005;33:1292\u20138.","journal-title":"Exp Hematol"},{"key":"1626_CR28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","volume":"53","author":"T Kempf","year":"2007","unstructured":"Kempf T, Horn-Wichmann R, Brabant G, et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem. 2007;53:284\u201391.","journal-title":"Clin Chem"},{"key":"1626_CR29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.febslet.2009.02.006","volume":"583","author":"M Akiyama","year":"2009","unstructured":"Akiyama M, Okano K, Fukada Y, et al. Macrophage inhibitory cytokine MIC-1 is upregulated by short-wavelength light in cultured normal human dermal fibroblasts. FEBS Lett. 2009;583:933\u20137.","journal-title":"FEBS Lett"},{"key":"1626_CR30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.109.213116","volume":"106","author":"T Ago","year":"2010","unstructured":"Ago T, Kuroda J, Pain J, et al. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010;106:1253\u201364.","journal-title":"Circ Res"},{"key":"1626_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V122.21.21.21","volume":"122","author":"K L\u00e9on","year":"2013","unstructured":"L\u00e9on K, Grace J, Elizabeta N, et al. The erythroid factor erythroferrone and its role in iron homeostasis. Blood. 2013;122:21\u20134.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1626-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1626-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1626-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T13:06:29Z","timestamp":1598101589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1626-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1626-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]}}}